Literature DB >> 8252975

Endotoxin in human disease. Part 2: Biologic effects and clinical evaluations of anti-endotoxin therapies.

C A Manthous1, J B Hall, R W Samsel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8252975     DOI： 10.1378/chest.104.6.1872

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.

Authors:  M S H El-Awady; S V Smirnov; M L Watson
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

Review 2.  Is sepsis a mediator-inhibitor mismatch?

Authors:  M Lamy; G Deby-Dupont
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

Review 3.  The role of the microcirculation in multiple organ dysfunction syndrome (MODS): a review and perspective.

Authors:  C J Kirkpatrick; F Bittinger; C L Klein; S Hauptmann; B Klosterhalfen
Journal:  Virchows Arch       Date:  1996-02       Impact factor: 4.064

4.  Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease.

Authors:  John D Bowman; Salim Surani; Michael A Horseman
Journal:  Curr Cardiol Rev       Date:  2017
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.